Pasireotide Therapy in Patients With Nelson’s Syndrome
by on Tuesday, June 12th, 2012 | No Comments
Condition: Nelson Syndrome
Intervention: Drug: Pasireotide
Sponsors: Sheffield Teaching Hospitals NHS Foundation Trust; Sheffield Teaching Hospitals NHS Foundation Trust; Novartis; Christie Hospital NHS Foundation Trust; Oxford University Hospitals NHS Trust; Barts & The London NHS Trust
Recruiting – verified June 2012
Continue reading here: Pasireotide Therapy in Patients With Nelson’s Syndrome